Corbus Pharmaceuticals Holdings, Inc. — Form D
Corbus Pharmaceuticals Holdings, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-12. The offering totals $30K, of which $20K was reported sold. Industry: Investing.
Offering
- Filed: 2014-03-12
- Form: D
- Accession: 0001595097-14-000005
- Industry: Investing
- Exemptions: 06b
- Total offering: $30K
- Amount sold: $20K
- Remaining: $10K
- Investors: 3
- Date of first sale: 2014-03-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-213463
Issuer
- Name: Corbus Pharmaceuticals Holdings, Inc.
- CIK: 0001595097
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 142 WEST 57TH STREET, NEW YORK, NY, 10019
- Phone: 646-367-5905
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| John Brancaccio | Executive Officer | San Diego, CA |
| David Hochman | Executive Officer | Cleveland, OH |
| Yuval Cohen | Director | Herzliya Pituach, L3 |
| Yuval Cohen | Executive Officer | Herzliya Pituach, L3 |
| Mark Tepper | Executive Officer | Newton, MA |
| David Hochman | Director | Cleveland, OH |
| Robert Zurier | Executive Officer | Wyckoff, NJ |
| Alan Holmer | Director | Farmingham, MA |
| Sean Moran | Executive Officer | Newton, MA |
Other filings by this issuer (2)
More